Example of marketing dashboard of a Semaglutide GLP-1 medical practice
reduce to 1.7 mg if not tolerated Zepbound Start: 2.5 mg weekly for 4 weeks, then titrate to 5, 10, or 15 mg Intermediate titration doses (7.5, 12.5 mg) are sometimes not covered beyond 4 weeks Missed doses
P.HendershotC
Individual results will vary based on factors including age, baseline weight, metabolic health, consistency of use, lifestyle factors, genetic factors, current medications, and other individual variables
Interestingly, the prevalence of additives has increased in parallel with the end of the shortage period, suggesting that some compounders may be utilizing these modifications to differentiate their products or navigate regulatory ambiguity
Reduced procedural complexity compared to intravenous delivery